article · IJTLD OPEN
The 2nd International Post-Tuberculosis Symposium aimed to raise global awareness and empower communities affected by tuberculosis (TB) to shape the agenda for post-TB care. With an estimated 155 million TB survivors at risk of disability, the multidisciplinary event brought together clinicians, researchers, survivors, funders, and policymakers. Its objectives included updating knowledge on post-TB life and illness, identifying research priorities, and fostering collaborations. Ten working groups covered diverse themes, from patient engagement and epidemiology to various physical and psychological complications, prevention, and advocacy. The symposium successfully provided updates, highlighted critical research needs, and advanced the standardisation of post-TB outcomes and definitions.
With millions of tuberculosis survivors facing potential long-term disabilities, understanding and addressing post-TB health issues is crucial. This symposium helped to consolidate knowledge, identify critical research gaps, and foster collaboration among diverse stakeholders, ensuring that the needs of survivors are recognised and integrated into future care and policy.
This abstract describes a symposium focused on research prioritisation, collaboration, and standardisation in post-tuberculosis care. It does not indicate any specific application pathways, commercial products, or services, nor does it suggest a readiness level for market entry.
AI-generated from the published abstract. Always read the original work before citing.
In 2020, it was estimated that there were 155 million survivors of TB alive, all at risk of possible post TB disability. The 2<sup>nd</sup> International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to increase global awareness and empower TB-affected communities to play an active role in driving the agenda. We aimed to update knowledge on post-TB life and illness, identify research priorities, build research collaborations and highlight the need to embed lung health outcomes in clinical TB trials and programmatic TB care services. The symposium was a multidisciplinary meeting that included clinicians, researchers, TB survivors, funders and policy makers. Ten academic working groups set their own goals and covered the following thematic areas: 1) patient engagement and perspectives; 2) epidemiology and modelling; 3) pathogenesis of post-TB sequelae; 4) post-TB lung disease; 5) cardiovascular and pulmonary vascular complications; 6) neuromuscular & skeletal complications; 7) paediatric complications; 8) economic-social and psychological (ESP) consequences; 9) prevention, treatment and management; 10) advocacy, policy and stakeholder engagement. The working groups provided important updates for their respective fields, highlighted research priorities, and made progress towards the standardisation and alignment of post-TB outcomes and definitions.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.5588/ijtldopen.23.0619
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
